About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Digestive Diseases
›
Top Articles
Digestive Diseases
Gastroenterology
3
(top 5%)
Impact Factor
3.5
(top 5%)
extended IF
70
(top 6%)
H-Index
899
authors
2.3K
papers
42.2K
citations
4.5K
citing journals
26K
citing authors
Most Cited Articles of Digestive Diseases in 2011
Title
Year
Citations
Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version
2011
619
Colon cancer: a civilization disorder
2011
166
Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery
2011
105
The bile acid membrane receptor TGR5: a valuable metabolic target
2011
89
The intriguing relationship of Helicobacter pylori infection and acid secretion in peptic ulcer disease and gastric cancer
2011
64
Metagenomics: key to human gut microbiota
2011
61
ASH and NASH
2011
59
Molecular pathogenesis of hepatocellular carcinoma: altering transforming growth factor-β signaling in hepatocarcinogenesis
2011
59
Gallstones: environment, lifestyle and genes
2011
53
Complications of peptic ulcer disease
2011
52
Epigenetics: principles and practice
2011
52
Escherichia coli Nissle 1917 (Mutaflor): new insights into an old probiotic bacterium
2011
51
Mechanisms balancing tolerance and immunity in the liver
2011
49
Immune control of hepatitis B virus
2011
47
Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis
2011
45
Indications for the use of probiotics in gastrointestinal diseases
2011
44
Hygiene and other early childhood influences on the subsequent function of the immune system
2011
44
Des-γ-carboxyprothrombin may be a promising biomarker to determine the therapeutic efficacy of sorafenib for hepatocellular carcinoma
2011
44
Gut microbiota and inflammatory bowel disease
2011
42
Gut microbiota and its pathophysiology in disease paradigms
2011
41
Environmental risk factors for chronic pancreatitis and pancreatic cancer
2011
41
TGR5 in the biliary tree
2011
41
Etiopathogenetic principles and peptic ulcer disease classification
2011
41
Contribution of gut microbiota to colonic and extracolonic cancer development
2011
40
Bile acid signaling in fetal tissues: implications for intrahepatic cholestasis of pregnancy
2011
38
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.